
Baidu Releases Quarterly Financial Report, Set to Buy JOYY’s Livestreaming Operations in China
On Nov. 17, Baidu released its financial results for the third quarter of 2020, ending on Sept. 30.
Showing 12 of 13065 posts
On Nov. 17, Baidu released its financial results for the third quarter of 2020, ending on Sept. 30.
Tim Cook, CEO of Apple, has been named chairman of the advisory board for Tsinghua University’s School of Economics and Management.
Baichuan releases its third large-scale model, Wang Xiaochuan: The opportunity for large models may not necessarily be limited to big companies.
Douyin emphasized the potential for growth in the interest-based e-commerce sector, with their platform's GMV growing by over 80% in the past year alone.
Xiaomi has taken a crucial step in car manufacturing by obtaining the qualification for electric vehicle production.
On January 24, AI startup HeyGen unveiled a motion control feature, enabling complex full-body movements for virtual avatars.
NIO's third factory has recently started construction, with a single shift capacity of 100,000 units. It will be used for the production of future NIO and ONVO brands products.
Following JD Logistics' acquisition of Deppon, its performance will soon be integrated into JD.com's system. Accordingly, Deppon's senior management team has undergone a large-scale adjustment.
Google announced it purchased the Pixel HTC intelligent mobile phone team for $1.1 billion. SEE ALSO: Google Backs Another Chinese Startup: Provides $120M to C...
Quxiaomian, a restaurant founded by Charles Lu Zhengyao, former chairman of Luckin Coffee, is seeking a new round of financing.
Wang Jianwei, Senior Vice President of Kuaishou, revealed at the company's 2022 Photosynthetic Creators Conference on July 29 that the firm will be conducting alpha tests of a creator version of its short video app this year.
Junshi Biosciences, a Chinese biopharmaceutical company, announced on January 18 that the country's medical products authorities had accepted a new drug application for Deuremidevir Hydrobromide Tablets (project code: JT001/VV116) for the treatment of COVID-19.